BM
Last reporting period 30 Jun, 2024
Updated —
Last price
—
Market cap $B
100.34
Exchange
XSWX - Six Swiss Exchange
1.2
Last period Current ratio
-46%
Current ratio has decreased in 5 years
What is Current ratio ?
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
See also Bristol-Myers
Company Analysis
BMY.SW valuation, rating, competitors, insights and company profile
Eyestock Rating
BMY.SW financial analysis by Eyestock methodology
Valuation
BMY.SW valuation using historical relative method
Statements
BMY.SW Income Statements, Balance Sheet and Cash Flow Statements
Dividends
BMY.SW dividend yield and annual dividend
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
Bristol-Myers`s Current ratio for the last twelve months ended 2024-06-30 is 1.2
